SIGMAR1 and neoplasm: Current investigations [30] show strong expression of Sig1R and correlation with pathologic tumor tissue in human esophageal squamous cell carcinoma [36], prostate cancer [37,38], myeloma [39], melanoma [20,40], and glioma [41].